acute dystonia
Recently Published Documents


TOTAL DOCUMENTS

164
(FIVE YEARS 19)

H-INDEX

18
(FIVE YEARS 1)

2021 ◽  
Vol 11 (2) ◽  
pp. 156-158
Author(s):  
Airenakho Emorinken ◽  
Oluwaseun Remi Agbadaola

Acute dystonic reactions are the most prevalent extrapyramidal adverse effects associated with metoclopramide. It could be mistaken for a variety of other conditions, such as seizures, tetanus, and encephalitis, to name a few possibilities. We present a case of a 26-year-old female misdiagnosed as having an epileptic seizure who was rushed to the emergency unit with an involuntary bilateral upward deviation of the eyes, spasm, stiffness, lateral deviation of the neck, and protrusion of the tongue. Symptoms occurred 36 hours after the commencement of metoclopramide, used to treat nausea and vomiting in the referring hospital. All the laboratory work was normal. The drug was discontinued and 5 mg of intravenous biperiden was administered. The symptoms subsided in about 10 minutes with no recurrence. Metoclopramide-induced acute dystonia not only creates an anxious environment for patients but may also be life-threatening. Due to the high probability of misdiagnosis, detailed drug history and a high index of suspicion are critical in making the correct diagnosis.


2021 ◽  
pp. 201010582110408 ◽  
Author(s):  
Howard Cai Hao Khoe ◽  
Vivian Shi Yin Wong

This report documents a rare case of delayed-onset multiple acute dystonias after treatment with low dose intramuscular (IM) haloperidol lactate injection in a setting of non-neuroleptic drug overdose. The drug–drug interactions between haloperidol and high levels of paracetamol and naproxen are deliberated upon. A 25-year-old Asian female was admitted after an intentional overdose of medications (paracetamol, naproxen and pregabalin). She received 5 mg of IM haloperidol injection for agitation. 21 hours later she experienced mild intermittent ocular deviation in an upward and outward direction and generalised stiffness, which were self-resolving. An hour later, she required another 2.5 mg of IM haloperidol injection for further agitation. In the 35 hours following her first IM haloperidol (13 hours after the second IM haloperidol), she developed a total of three episodes of oculogyric crisis (OGC) with torticollis. Each episode was treated promptly with IM diphenhydramine 25 mg, and there was remission of symptoms within 15 minutes of treatment. An objective causality assessment revealed a definite relationship between the episodes of acute dystonia with IM haloperidol therapy. Where oral alternatives and IM atypical antipsychotics/benzodiazepines are unavailable, rapid tranquillisation with a high-potency typical antipsychotic is a possibility. However, consideration should be made to combine haloperidol with an anticholinergic agent as prophylaxis against acute dystonia, especially in the setting of drug overdose, even if it is that of a non-neuroleptic drug (in this case, paracetamol and naproxen).


Author(s):  
Faruk Kurhan ◽  
Gülsüm Zuhal Kamış ◽  
Emine füsun Akyüz Çim

2021 ◽  
Vol 14 (2) ◽  
pp. e237065
Author(s):  
May Honey Ohn ◽  
Jiann Lin Loo ◽  
Khin Maung Ohn

Atraumatic trismus can be one of the presentations of medication-induced acute dystonia, particularly by antipsychotics and less commonly antidepressants. A case of an unusual emergency presentation of atraumatic trismus on initiation of duloxetine is reported. The patient was a 40-year-old woman experiencing sudden difficulty in mouth opening and speaking due to a stiffened jaw after taking 5 days of duloxetine prescribed for her fibromyalgia-related chest pain. Assessment of vital signs is prudent to ensure there is no laryngeal involvement. Other physical examinations and her recent investigations were unremarkable. She was treated for acute dystonia and intravenous procyclidine was given together with oral diazepam. Her symptoms improved immediately and her duloxetine was suggested to be stopped. To our knowledge, this is the first case of isolated trismus induced by duloxetine. Clinicians should be aware of this risk, especially considering the limitation of important physiological functions (such as swallowing, eating, etc) associated with this condition.


2021 ◽  
Vol 10 (2) ◽  
pp. 1034
Author(s):  
Zahra Poursharif ◽  
Parvane Rashidpour ◽  
Mina Ayatollahi ◽  
Elham Farzannejad

2020 ◽  
Vol 79 ◽  
pp. e106-e107
Author(s):  
E. Aciman Demirel ◽  
B. Karpuz ◽  
S. Erturk ◽  
V. Cakir Kardes

Author(s):  
Cansu MERCAN IŞIK ◽  
Belde DEMİRCİ ◽  
Seda Aybüke SARI ◽  
Ayla UZUN ÇİÇEK

Sign in / Sign up

Export Citation Format

Share Document